Company news: Elixinol/The Sustainable Nutrition Group; Emyria by Steve Jones August 8, 2023April 30, 2024 Shares in The Sustainable Nutrition Group (TSN) will be suspended from the ASX at close of […]
Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
Elixinol wins A$835k arbitration ruling in stoush with German operator by Steve Jones February 14, 2023April 30, 2024
Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023
Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
Strategic review continues at Elixinol as management mull sale or merger by Steve Jones May 4, 2022April 29, 2024
